Shafer Christina
SEC insider (Form 3/4/5 filer). CIK 0001934412. Chief Commercial Officer at Neurogene Inc. (NGNE) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2026. Located in NEW YORK, NY.
Companies Shafer Christina has filed insider reports for
- Neurogene Inc. (NGNE): Officer, Chief Commercial Officer
- MARINUS PHARMACEUTICALS, INC. (MRNS): Officer, CHIEF COMMERCIAL OFFICER
Shafer Christina
CIK: 0001934412
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 5, 2026NGNE
Neurogene Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
120K shares- - Feb 11, 2025MRNS
MARINUS PHARMACEUTICALS, INC.
DispositionDirect48.6K shares at avg. $0.55$27K - Feb 7, 2025MRNS
MARINUS PHARMACEUTICALS, INC.
DispositionDirect18.8K shares at avg. $0.55$10K
1-3 of 3 transactions